‘June will be huge’: Avecho boss bullish ahead of CBD trial analysis by Steve Jones March 26, 2026March 26, 2026 Avecho Biotechnology chief executive Paul Gavin has spoken of his belief that the company is on […]
We just couldn’t grow fast enough, Helius CEO reveals amid warning for firms to be ‘realistic’ by Adam Sheldon March 26, 2026March 26, 2026
Autism data hits ‘registration benchmark’ as Neurotech prepares for Phase III clinical trial by Adam Sheldon March 25, 2026March 26, 2026
MP introduces bill in WA to legalise personal cannabis use for adults by Adam Sheldon March 25, 2026June 8, 2026
Domestic market could ‘double’ on back of driving law reform: Bioxyne by Adam Sheldon March 25, 2026March 25, 2026
Court adjourns Montu case again as proceedings approach second anniversary by Steve Jones March 24, 2026March 25, 2026
Don’t repeat the mistakes that caused the benzo and opioid crises, addiction specialist warns by Adam Sheldon March 23, 2026March 25, 2026
More job losses at Montu as sales chief Craig Thompson departs by Steve Jones March 19, 2026March 19, 2026
Industry hits back at Lancet paper for ‘rifling through the bones of an old, musty evidence base’ by Steve Jones March 19, 2026March 19, 2026
